Ruth Harman

I joined the Oncology Clinical Trials Office (OCTO) as a Trial Manager in May 2019. Prior to this I was a Research Administrator for the HOME Study in the University’s Department of Psychiatry.

I am currently working on the following trials:

ARCADIAN trial – a phase I study to assess the safety of combining the drug atovaquone with concurrent chemoradiotherapy in locally advanced Non-Small Cell Lung Cancer.

CHARIOT – A phase I dose escalation safety study combining the ATR inhibitor M6620 with chemoradiotherapy in oesophageal cancer & other solid cancers using time to event continual reassessment method.

CYTOFLOC – Evaluation of a Non‐Endoscopic Immunocytological Device (Cytosponge™) for post chemo‐radiotherapy surveillance in patients with oesophageal cancer – a feasibility study.

Further information on these trials and other OCTO studies can be found here.